Retraction: Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress (Neural Plasticity (2016) (7258201) DOI: 10.1155/2016/7258201);Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Ślusarczyk, Joanna ^a   Trojan, Ewa ^a   Głombik, Katarzyna ^a   Chamera, Katarzyna ^a   Roman, Adam ^a   Budziszewska, Bogusława ^a   Basta Kaim, Agnieszka ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE RECEPTOR; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR; V28 RECEPTOR; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; MICROGLIA; MICROGLIAL CELL CULTURE; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PRENATAL STRESS; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; GENETICS; MENTAL STRESS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CX3CL1; FEMALE; INTERLEUKINS; MICROGLIA; NITRIC OXIDE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOKINE; RECEPTORS, HIV; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84973402694     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2018/6924505     Document Type: Erratum

References (55)

1. M. Maes, R. Yirmyia, J. Noraberg et al., "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression, " Metabolic Brain Disease, vol. 24, no. 1, pp. 27-53, 2009.
2. Y. Dowlati, N. Herrmann, W. Swardfager et al., "Ameta-analysis of cytokines in major depression, " Biological Psychiatry, vol. 67, no. 5, pp. 446-457, 2010.
3. P. Gaecki, J. Szemraj, A. Florkowski et al., "Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders, " Neuroendocrinology Letters, vol. 31, no. 1, pp. 97-102, 2010.
4. Y. Nakagawa and K. Chiba, "Role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases, " Pharmaceuticals, vol. 7, no. 12, pp. 1028-1048, 2014.
5. E. Szczesny, A. Basta-Kaim, J. Slusarczyk et al., "The impact of prenatal stress on insulin-like growth factor-1 and proinflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins, " Journal of Neuroimmunology, vol. 276, no. 1-2, pp. 37-46, 2014.
6. M. J. Stuart, G. Singhal, and B. T. Baune, "Systematic review of the neurobiological relevance of chemokines to psychiatric disorders, " Frontiers in Cellular Neuroscience, vol. 9, article 357, 2015.
7. R. Yirmiya, N. Rimmerman, and R. Reshef, "Depression as a microglial disease, " Trends in Neurosciences, vol. 38, no. 10, pp. 637-658, 2015.
8. S. D. Bilbo and J. M. Schwarz, "The immune system and developmental programming of brain and behavior, " Frontiers in Neuroendocrinology, vol. 33, no. 3, pp. 267-286, 2012.
9. A. Shemer, D. Erny, S. Jung, and M. Prinz, "Microglia plasticity during health and disease: an immunological perspective, " Trends in Immunology, vol. 36, no. 10, pp. 614-624, 2015.
10. M. Antonietta Ajmone-Cat, M. Mancini, R. De Simone, P. Cilli, and L. Minghetti, "Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures, " Glia, vol. 61, no. 10, pp. 1698-1711, 2013.
11. J. Slusarczyk, E. Trojan, K. Gombik et al., "Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells, " Frontiers in Cellular Neuroscience, vol. 9, article 82, 2015.
12. K. Kierdorf and M. Prinz, "Factors regulating microglia activation, " Frontiers in Cellular Neuroscience, vol. 7, article 44, 2013.
13. E. A. Eugenin, G. Dyer, T. M. Calderon, and J. W. Berman, "HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent echanism: possible role in NeuroAIDS, " Glia, vol. 49, no. 4, pp. 501-510, 2005.
14. K. Biber, J. Vinet, and H. W. G. M. Boddeke, "Neuron-microglia signaling: chemokines as versatile messengers, " Journal of Neuroimmunology, vol. 198, no. 1-2, pp. 69-74, 2008.
15. M. Riek-Burchardt, A. Kolodziej, P. Henrich-Noack, K. G. Reymann, V. Höllt, and R. Stumm, "Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia, " Neuropharmacology, vol. 58, no. 1, pp. 199-207, 2010.
16. F. Pujol, P. Kitabgi, and H. Boudin, "The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons, " Journal of Cell Science, vol. 118, no. 5, pp. 1071-1080, 2005.
17. R. C. Paolicelli, G. Bolasco, F. Pagani et al., "Synaptic pruning by microglia is necessary for normal brain development, " Science, vol. 333, no. 6048, pp. 1456-1458, 2011.
18. H. Kettenmann, F. Kirchhoff, and A. Verkhratsky, "Microglia: new roles for the synaptic stripper, " Neuron, vol. 77, no. 1, pp. 10-18, 2013.
19. S. B. Oh, P. B. Tran, S. E. Gillard, R. W. Hurley, D. L. Hammond, and R. J. Miller, "Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons, " The Journal of Neuroscience, vol. 21, no. 14, pp. 5027-5035, 2001.
20. S. B. Oh, C. Cho, and R. J. Miller, "Electrophysiological analysis of neuronal chemokine receptors, " Methods, vol. 29, no. 4, pp. 335-344, 2003.
21. A. Réaux-Le Goazigo, J. Van Steenwinckel, W. Rostène, and S. Mélik Parsadaniantz, "Current status of chemokines in the adult CNS, " Progress in Neurobiology, vol. 104, pp. 67-92, 2013.
22. S. Mélik-Parsadaniantz and W. Rostène, "Chemokines and neuromodulation, " Journal of Neuroimmunology, vol. 198, no. 1-2, pp. 62-68, 2008.
23. J. K. Harrison, Y. Jiang, S. Chen et al., "Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10896-10901, 1998.
24. K. Hatori, A. Nagai, R. Heisel, J. K. Ryu, and S. U. Kim, "Fractalkine and fractalkine receptors in human neurons and glial cells, " Journal of Neuroscience Research, vol. 69, no. 3, pp. 418-426, 2002.
25. R. C. Paolicelli, K. Bisht, and M.-è. Tremblay, "Fractalkine regulation of microglial physiology and consequences on the brain and behavior, " Frontiers in Cellular Neuroscience, vol. 8, article 129, 2014.
26. M. K. Zabel and W. M. Kirsch, "From development to dysfunction: microglia and the complement cascade in CNS homeostasis, " Ageing Research Reviews, vol. 12, no. 3, pp. 749-756, 2013.
27. A. W. Corona, D. M. Norden, J. P. Skendelas et al., "Indoleamine 2, 3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice, " Brain, Behavior, and Immunity, vol. 31, pp. 134-142, 2013.
28. C. Limatola and R. M. Ransohoff, "Modulating neurotoxicity through CX3CL1/CX3CR1 signaling, " Frontiers in Cellular Neuroscience, vol. 8, article 229, 2014.
29. Y. Wolf, S. Yona, K.-W. Kim, and S. Jung, "Microglia, seen from the CX3CR1 angle, " Frontiers in Cellular Neuroscience, vol. 7, article 26, 2013.
30. A. D. Bachstetter, J. M. Morganti, J. Jernberg et al., "Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats, " Neurobiology of Aging, vol. 32, no. 11, pp. 2030-2044, 2011.
31. J. T. Rogers, J. M. Morganti, A. D. Bachstetter et al., "CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity, " The Journal of Neuroscience, vol. 31, no. 45, pp. 16241-16250, 2011.
32. V. Zujovic, J. Benavides, X. Vigé, C. Carter, and V. Taupin, "Fractalkine modulates TNF secretion and neurotoxicity induced by microglial activation, " Glia, vol. 29, no. 4, pp. 305-315, 2000.
33. T. Mizuno, J. Kawanokuchi, K. Numata, and A. Suzumura, "Production and neuroprotective functions of fractalkine in the central nervous system, " Brain Research, vol. 979, no. 1-2, pp. 65-70, 2003.
34. A. Lyons, A. M. Lynch, E. J. Downer et al., "Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro, " Journal of Neurochemistry, vol. 110, no. 5, pp. 1547-1556, 2009.
35. S. Maccari, P. V. Piazza, M. Kabbaj, A. Barbazanges, H. Simon, and M. Le Moal, "Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress, " The Journal of Neuroscience, vol. 15, no. 1, part 1, pp. 110-116, 1995.
36. A. Basta-Kaim, E. Szczesny, K. Glombik et al., "Prenatal stress affects insulin-like growth factor-1 (IGF-1) level and IGF-1 receptor phosphorylation in the brain of adult rats, " European Neuropsychopharmacology, vol. 24, no. 9, pp. 1546-1556, 2014.
37. C. Limatola, C. Lauro, M. Catalano et al., "Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity, " Journal ofNeuroimmunology, vol. 166, no. 1-2, pp. 19-28, 2005.
38. á. Polyák, S. Ferenczi, Á. Dénes et al., "The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity, " Brain, Behavior, and Immunity, vol. 38, pp. 25-35, 2014.
39. M. M. Pabon, A. D. Bachstetter, C. E. Hudson, C. Gemma, and P. C. Bickford, "CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease, " Journal of Neuroinflammation, vol. 8, article 9, 2011.
40. C. Lauro, M. Catalano, F. Trettel, and C. Limatola, "Fractalkine in the nervous system: neuroprotective or neurotoxic molecule" Annals of the New York Academy of Sciences, vol. 1351, no. 1, pp. 141-148, 2015.
41. W. J. Schwaeble, C. M. Stover, T. J. Schall et al., "Neuronal expression of fractalkine in the presence and absence of inflammation, " FEBS Letters, vol. 439, no. 3, pp. 203-207, 1998.
42. Y. Pan, C. Lloyd, H. Zhou et al., "Neurotactin, a membraneanchored chemokine upregulated in brain inflammation, " Nature, vol. 387, no. 6633, pp. 611-617, 1997.
43. P. M. Hughes, M. S. Botham, S. Frentzel, A. Mir, and V. H. Perry, "Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS, " Glia, vol. 37, no. 4, pp. 314-327, 2002.
44. J. L. Bollinger, C. M. Bergeon Burns, and C. L. Wellman, "Differential effects of stress on microglial cell activation in male and femalemedial prefrontal cortex, " Brain, Behavior, and Immunity, vol. 52, pp. 88-97, 2016.
45. S. Hellwig, S. Brioschi, S. Dieni et al., "Altered microglia morphology and higher resilience to stress-induced depressionlike behavior in CX3CR1-deficient mice, " Brain, Behavior, and Immunity, 2015.
46. G. Milior, C. Lecours, L. Samson et al., "Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress, " Brain, Behavior, and Immunity, 2015.
47. A. W. Corona, Y. Huang, J. C. O'Connor et al., "Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide, " Journal of Neuroinflammation, vol. 7, article 93, 2010.
48. E. W. G. M. Boddeke, I. Meigel, S. Frentzel, K. Biber, L. Q. Renn, and P. Gebicke-Härter, "Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia, " European Journal of Pharmacology, vol. 374, no. 2, pp. 309-313, 1999.
49. A. M. Wynne, C. J. Henry, Y. Huang, A. Cleland, and J. P. Godbout, "Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge, " Brain, Behavior, and Immunity, vol. 24, no. 7, pp. 1190-1201, 2010.
50. H. A. Mattison, H. Nie, H. Gao, H. Zhou, J.-S. Hong, and J. Zhang, "Suppressed pro-inflammatory response ofmicroglia in CX3CR1 knockout mice, " Journal of Neuroimmunology, vol. 257, no. 1-2, pp. 110-115, 2013.
51. S. Chen, D. Luo, W. J. Streit, and J. K. Harrison, "TGF 1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia, " Journal of Neuroimmunology, vol. 133, no. 1-2, pp. 46-55, 2002.
52. D. M. Norden, A. M. Fenn, A. Dugan, and J. P. Godbout, "TGF produced by IL-10 redirected astrocytes attenuates microglial activation, " Glia, vol. 62, no. 6, pp. 881-895, 2014.
53. R. Pannu and I. Singh, "Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms, " Neurochemistry International, vol. 49, no. 2, pp. 170-182, 2006.
54. S. Shen, S. Yu, J. Binek et al., "Distinct signaling pathways for induction of type II NOS by IFN and LPS in BV-2 microglial cells, " Neurochemistry International, vol. 47, no. 4, pp. 298-307, 2005.
55. J. P. Kiss, "Role of nitric oxide in the regulation of monoaminergic neurotransmission, " Brain Research Bulletin, vol. 52, no. 6, pp. 459-466, 2000.